Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Value Fund median (27 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 12 Dec 2018 – 20 Aug 2026, limited by Union Value Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Union Value Fund | Nifty 500 |
|---|---|---|
| 12 Dec 2018 | ₹100.00 | ₹100.00 |
| 03 Aug 2019 | ₹96.83 | ₹99.14 |
| 24 Mar 2020 | ₹69.41 | ₹70.56 |
| 13 Nov 2020 | ₹114.16 | ₹115.14 |
| 05 Jul 2021 | ₹148.71 | ₹150.59 |
| 24 Feb 2022 | ₹152.87 | ₹152.70 |
| 16 Oct 2022 | ₹166.53 | ₹164.22 |
| 07 Jun 2023 | ₹183.37 | ₹177.43 |
| 27 Jan 2024 | ₹235.05 | ₹214.96 |
| 17 Sep 2024 | ₹285.74 | ₹265.69 |
| 09 May 2025 | ₹257.92 | ₹240.26 |
| 29 Dec 2025 | ₹285.35 | ₹262.50 |
| 20 Aug 2026 | ₹289.01 | ₹260.63 |
| Metric | Union · Regular · IDCW NAV ₹29.19 Very High risk ★★★★★ | Category median Value Fund · 27 funds |
|---|---|---|
| +3.40% | +1.55% | |
| +13.33% | +10.75% | |
| +13.41% | +10.54% | |
| — | +7.06% | |
| +14.80% | +8.32% | |
| +12.24% | — | |
| +19.32% | +10.45% | |
| +19.62% | +8.52% | |
| — | +6.67% | |
| Risk | ||
| 14.72% | 15.42% | |
| 0.46 | 0.30 | |
| 0.62 | 0.39 | |
| -37.73% | -47.99% | |
| Nifty 500 | — | |
| +1.38% | -0.99% | |
| 0.91 | 0.95 | |
| 97.1% | 99.4% | |
| 88.6% | 105.5% | |
| 2.73% | 2.35% | |
| ₹374.67Cr | ₹1,405Cr | |
| 1.00% | — | |
| None | — | |
| ₹500 | — | |
| ₹1.00K | — | |
| 47% | 40% | |
| Gaurav Chopra | — | |
| 12 Dec 2018 | — | |
| 67 | — | |
| 34.4% | — | |
| 2.3% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.